Certara, Inc. · NASDAQ:CERT

Certara — Fact Sheet (April 2025)

4 slides from Certara's fact sheet, April 2025

  1. Slide 1: Shorten the Design-Make-Test-Analyze Cycle with D360

    Shorten the Design-Make- Test-Analyze Cycle with D360

  2. Slide 2: Spend more time on science and less time on data wrangling

    Spend more time on science and less time on data wrangling The faster that scientists determine structure-activity That’s why pharmaceutical companies and biotechs relationships (SAR), the faster they can identify and of all sizes trust industry-leading D360™ software. advance their most promising l

  3. Slide 3: 6,000+ scientists from big pharma to small biotech use D360

    6,000+ scientists from big pharma to small biotech use D360 to access discovery data quickly and easily One-Click Data Access Customizable dashboards Save time and improve with easily shareable widgets decision making for quick data retrieval. Self-Service Data Search Connects to multiple data sourc

  4. Slide 4: We need to be able to query, pivot and dive deep into our drug discovery data

    “We need to be able to query, pivot and dive deep into our drug discovery data, and D360 is the best platform we have found for that. Compared to our previous research informatics solution, D360 is saving us hundreds of hours annually on data analysis. That is an important contribution to our resear

Certara — Fact Sheet (April 2025) on 6ix